Neumann Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,498
Closed -$279K 76
2017
Q3
$279K Buy
1,498
+98
+7% +$17.4K 0.17% 69
2017
Q2
$241K Hold
1,400
0.16% 70
2017
Q1
$230K Hold
1,400
0.15% 70
2016
Q4
$205K Hold
1,400
0.13% 72
2016
Q3
$234K Hold
1,400
0.16% 71
2016
Q2
$213K Hold
1,400
0.14% 74
2016
Q1
$210K Hold
1,400
0.14% 77
2015
Q4
$227K Buy
+1,400
New +$220K 0.16% 74
2015
Q3
Sell
-1,400
Closed -$215K 78
2015
Q2
$215K Hold
1,400
0.14% 78
2015
Q1
$224K Hold
1,400
0.14% 80
2014
Q4
$223K Buy
+1,400
New +$218K 0.15% 82

Other funds holding AMGN

Neumann Capital Management's AMGN Position: Q4 2017 in Review

Neumann Capital Management sold out of Amgen (AMGN) in Q4 2017, closing a stake of 1,498 shares — an estimated $279K sold.

Neumann Capital Management first reported a position in AMGN in Q4 2014 and held it in 11 quarters. The position peaked at $279K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • Neumann Capital Management reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
  • Neumann Capital Management sold 1,498 Amgen shares in Q4 2017, an estimated $279K.
  • Neumann Capital Management first reported a position in Amgen in Q4 2014 and held it in 11 quarters.
  • Neumann Capital Management's Amgen position peaked at $279K in Q3 2017.
  • 1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Neumann Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.